| pubmed-article:12843233 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C0917798 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:12843233 | lifeskim:mentions | umls-concept:C1704711 | lld:lifeskim |
| pubmed-article:12843233 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:12843233 | pubmed:dateCreated | 2003-7-4 | lld:pubmed |
| pubmed-article:12843233 | pubmed:abstractText | 1-(11)C-Octanoate is a potential tracer for studying astroglial function in PET. To evaluate the usefulness of 1-(11)C-octanoate for studying ischemic stroke, we investigated the brain distribution of 1-(14)C-octanoate and compared it with N-isopropyl-p-(123)I-iodoamphetamine ((123)I-IMP) distribution (cerebral blood flow), (123)I-iomazenil ((123)I-IMZ) distribution (neuronal viability based on (123)I-IMZ binding to benzodiazepine receptors), and hematoxylin-eosin stain (morphologic changes) in a rat model of focal cerebral ischemia. | lld:pubmed |
| pubmed-article:12843233 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12843233 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12843233 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12843233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12843233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12843233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12843233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12843233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12843233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12843233 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12843233 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12843233 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:KugeYujiY | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:SekiKoh-ichiK | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:OhkuraKazueK | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:TsukamotoErik... | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:TamakiNagaraN | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:UenoSatoshiS | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:HikosakaKenji... | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:NishijimaKen-... | lld:pubmed |
| pubmed-article:12843233 | pubmed:author | pubmed-author:KajiTomohitoT | lld:pubmed |
| pubmed-article:12843233 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12843233 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:12843233 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12843233 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12843233 | pubmed:pagination | 1168-75 | lld:pubmed |
| pubmed-article:12843233 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:meshHeading | pubmed-meshheading:12843233... | lld:pubmed |
| pubmed-article:12843233 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12843233 | pubmed:articleTitle | Characteristic brain distribution of 1-(14)C-octanoate in a rat model of focal cerebral ischemia in comparison with those of (123)I-IMP and (123)I-iomazenil. | lld:pubmed |
| pubmed-article:12843233 | pubmed:affiliation | Departments of Tracer Kinetics and Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan. kuge@med.hokudai.ac.jp | lld:pubmed |
| pubmed-article:12843233 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12843233 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12843233 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12843233 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| pubmed-article:12843233 | pubmed:publicationType | Validation Studies | lld:pubmed |
